← Leaderboards
Karen O Anderson
University Of Texas Md Anderson Can Ctr
$1,749,395
Attributed
$1,749,395
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,749,395 · 1
By mechanism
R01$1,749,395 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Scott M Lippman$54,535,308
- Menashe Bareli$6,643,202
- Jeffrey Nicholas Myers$13,165,599
- Dean G Tang$12,952,203
- Keping Xie$7,782,417
Others in their field
Top investigators on “Autologous Transplantation”
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$42,684,494
- Mary M Horowitz · Medical College Of Wisconsin$38,654,527
- Keri Hammel · The Emmes Company, Llc$26,462,048
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Lynette Keyes-Elstein · Rho Federal Systems Division, Inc.$20,699,678
- Kathrin Plath · University Of California Los Angeles$16,303,053
Research focus
Autologous TransplantationBone Marrow TransplantationBreast NeoplasmsClinical ResearchClinical Trial Phase IFunctional AbilityHuman MortalityHuman SubjectMetastasisMultiple MyelomaNonhodgkin'S LymphomaPatient Care ManagementPatient Monitoring DevicePrognosisPsychological Aspect Of CancerQuality Of LifeSign /SymptomTerminal Patient Care
Grant awards (5)
SYMPTOMS OF TRANSPLANT PATIENTS NEAR THE END OF LIFE$436,947
R01 · FY2003 · CA
SYMPTOMS OF TRANSPLANT PATIENTS NEAR THE END OF LIFE$429,236
R01 · FY2002 · CA
SYMPTOMS OF TRANSPLANT PATIENTS NEAR THE END OF LIFE$416,840
R01 · FY2001 · CA
SYMPTOMS OF TRANSPLANT PATIENTS NEAR THE END OF LIFE$31,487
R01 · FY2001 · CA
SYMPTOMS OF TRANSPLANT PATIENTS NEAR THE END OF LIFE$434,885
R01 · FY2000 · CA